SEC Form 4 · accession 0001829126-26-009543
Veraxa Biotech AG - Post de-SPAC · VRXA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christoph Rudiger Antz
Officer — Chief Executive Officer · Director
Period of report
Aug 27, 2026
Accepted (ET)
Aug 31, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002079109
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 27, 2026 | P | 5,000 | $1.53 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.